ARS Pharmaceuticals, Inc.
Develops the first FDA-approved, needle-free epinephrine spray for severe allergic reactions.
SPRY | NDAQ
Overview
Corporate Details
- ISIN(s):
- US82835W1080
- LEI:
- Country:
- United States of America
- Address:
- 11682 EL CAMINO REAL, SUITE 300, 92130 SAN DIEGO
- Website:
- https://ars-pharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
ARS Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of treatments for patients with severe allergic reactions. The company is dedicated to creating patient-friendly, needle-free therapies to address challenges such as device portability, ease of use, and needle-related risks. Its lead product, neffy® (epinephrine nasal spray), is the first and only FDA-approved needle-free epinephrine product for the emergency treatment of Type I allergic reactions. neffy is designed as a non-invasive and easy-to-carry alternative to traditional auto-injectors, empowering patients and caregivers to administer treatment without hesitation.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all ARS Pharmaceuticals, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ARS Pharmaceuticals, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ARS Pharmaceuticals, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
